Ruchi Mathur, MD, FRCP(C)
Ruchi Mathur, MD, FRCP(C) is an Attending Physician with the Division of Endocrinology, Diabetes and Metabolism and Associate Director of Clinical Research, Recruitment and Phenotyping with the Center for Androgen Related Disorders, Department of Obstetrics and Gynecology at Cedars-Sinai Medical Center.
William C. Shiel Jr., MD, FACP, FACR
Dr. Shiel received a Bachelor of Science degree with honors from the University of Notre Dame. There he was involved in research in radiation biology and received the Huisking Scholarship. After graduating from St. Louis University School of Medicine, he completed his Internal Medicine residency and Rheumatology fellowship at the University of California, Irvine. He is board-certified in Internal Medicine and Rheumatology.
- What is myxedema coma?
- Who is affected by myxedema coma?
- What are the symptoms of hypothyroidism?
- What causes myxedema coma?
- What are triggers of myxedema coma?
- What are the symptoms of myxedema coma?
- How is myxedema coma diagnosed?
- What is the treatment for myxedema coma?
- How can myxedema coma be prevented?
- Patient Comments: Myxedema Coma - Causes and Triggers
- Patient Comments: Myxedema Coma - Symptoms
- Find a local Doctor in your town
What is myxedema coma?
Myxedema coma is a loss of brain function as a result of severe, longstanding low level of thyroid hormone in the blood (hypothyroidism). Myxedema coma is considered a life-threatening complication of hypothyroidism and represents the far more serious side of the spectrum of thyroid disease.
Who is affected by myxedema coma?
Myxedema coma is not common, but tends to be seen more frequently in elderly patients and in women. There is an increased incidence in the winter months, which is likely secondary to the extremes in temperature. Myxedema coma can actually result in death. Fortunately, the condition is rare.
Viewers share their comments
- Submit »
Find out what women really need.